Biohit, a biotech company based in Finland, has tapped Hefei Medicine to distribute its diagnostic products in China for undisclosed terms. The deal covers products such as the GastroPanel system, a blood-based biomarker assay used to detect Helicobacter pylori.
Biohit strikes Dx supply deal with Hefei Medicine
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||